规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Nrf2 is a nuclear factor that controls the expression and coordinated induction of a battery of genes that encode detoxifying enzymes, drug transporters, antiapoptotic proteins, and proteasomes[2]. NK-252 is a potential Nrf2 activator, which exhibits a great Nrf2-activating potential. NK-252 interacts with the domain containing the Nrf2-binding site of Keap1 in vitro binding studies. The administration of NK-252 significantly attenuated the progression of histologic abnormalities in rats[3]. NK-252 could potentiate the antitumor activity of multiple anticancer agent including vincristine (VCR), vinblastine, vindesine and actinomycin D in drug-resistant tumor cells and their parental drug-sensitive tumor cells. NK-252 at 5-10μM almost completely reversed VCR resistance in cultured VCR-resistant P388/VCR cells and at 1-10μM inhibited the photoaffinity labeling by [3H]azidopine of the cell-surface 170,000-molecular-weight P-glycoprotein[4]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.51mL 0.70mL 0.35mL |
17.53mL 3.51mL 1.75mL |
35.06mL 7.01mL 3.51mL |
CAS号 | 1414963-82-8 |
分子式 | C13H11N5O3 |
分子量 | 285.26 |
SMILES Code | O=C(NCC1=NC=CC=C1)NC2=NN=C(C3=CC=CO3)O2 |
MDL No. | MFCD28009512 |
别名 | |
运输 | 蓝冰 |
InChI Key | FNSCFQXZZNCDAI-UHFFFAOYSA-N |
Pubchem ID | 71618700 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
DMSO: 30 mg/mL(105.17 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|